# A Re-licensing Study to Assess the Efficacy of Inflexal V Formulated With WHO Recommended 2010/2011 Influenza Virus Strains for the Northern Hemisphere

> **NCT01306305** · PHASE4 · COMPLETED · sponsor: **Crucell Holland BV** · enrollment: 110 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Inflexal V

## Key facts

- **NCT ID:** NCT01306305
- **Lead sponsor:** Crucell Holland BV
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2010-07
- **Final completion:** 2010-07
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2013-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01306305

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01306305, "A Re-licensing Study to Assess the Efficacy of Inflexal V Formulated With WHO Recommended 2010/2011 Influenza Virus Strains for the Northern Hemisphere". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT01306305. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*